First Republic Investment Management, Inc. Fate Therapeutics Inc Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Fate Therapeutics Inc stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 132,334 shares of FATE stock, worth $472,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares

132,334

Previous 135,334 2.22%

Holding current value

$472,432

Previous $644,000 56.52%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$2.02 - $5.04 $6,060 - $15,120	-3,000 Reduced 2.22%	132,334 $280,000
Q2 2023 Jul 28, 2023	SELL	$4.76 - $6.59 $9,791 - $13,555	-2,057 Reduced 1.5%	135,334 $644,000
Q1 2023 May 11, 2023	BUY	$4.24 - $11.12 $515,249 - $1.35 Million	121,521 Added 765.73%	137,391 $783,000
Q4 2022 Feb 13, 2023	SELL	$9.86 - $23.83 $98 - $238	-10 Reduced 0.06%	15,870 $160,000
Q3 2022 Nov 03, 2022	SELL	$21.04 - $36.06 $4,060 - $6,959	-193 Reduced 1.2%	15,880 $356,000
Q2 2022 Aug 16, 2022	SELL	$17.78 - $42.39 $9,423 - $22,466	-530 Reduced 3.19%	16,073 $398,000
Q1 2022 May 16, 2022	SELL	$29.67 - $60.28 $58,212 - $118,269	-1,962 Reduced 10.57%	16,603 $644,000
Q4 2021 Feb 09, 2022	BUY	$47.84 - $64.34 $13,921 - $18,722	291 Added 1.59%	18,565 $1.09 Million
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $74,680 - $120,619	-1,260 Reduced 6.45%	18,274 $1.08 Million
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $20,982 - $28,866	-312 Reduced 1.57%	19,534 $1.7 Million
Q1 2021 May 14, 2021	SELL	$72.16 - $117.4 $38,533 - $62,691	-534 Reduced 2.62%	19,846 $1.64 Million
Q4 2020 Feb 16, 2021	BUY	$38.09 - $100.95 $53,364 - $141,430	1,401 Added 7.38%	20,380 $1.85 Million
Q3 2020 Nov 12, 2020	BUY	$30.41 - $40.5 $272,686 - $363,163	8,967 Added 89.56%	18,979 $759,000
Q2 2020 Aug 13, 2020	SELL	$20.21 - $35.23 $112,771 - $196,583	-5,580 Reduced 35.79%	10,012 $344,000
Q4 2019 Feb 14, 2020	BUY	$13.39 - $20.73 $31,600 - $48,922	2,360 Added 17.84%	15,592 $305,000
Q3 2019 Nov 08, 2019	SELL	$15.47 - $22.5 $377,468 - $549,000	-24,400 Reduced 64.84%	13,232 $205,000
Q4 2018 Feb 12, 2019	BUY	$11.48 - $16.98 $432,015 - $638,991	37,632 New	37,632 $483,000

Others Institutions Holding FATE

# of Institutions

190

Shares Held

123M

Call Options Held

15K

Put Options Held

14K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $346M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account

First Republic Investment Management, Inc. Fate Therapeutics Inc Transaction History